Engineered Therapeutic Probiotic System and Method

    公开(公告)号:US20240261341A1

    公开(公告)日:2024-08-08

    申请号:US18432028

    申请日:2024-02-04

    摘要: The claimed invention provides therapeutic as well as protective measures against colorectal cancer by utilizing genetically modified gut bacteria (101) in conjunction with an optimized diet high in cruciferous vegetable intake. According to the claimed system and method, engineered gut bacteria maximize the therapeutic value of the cruciferous vegetable diet to eradicate, offset or prophylactically prevent the onset of colorectal cancer. In the claimed invention gut bacteria Escherichia coli bind specifically to the heparan sulphate proteoglycan on colorectal cancer cells to secrete the enzyme myrosinase to transform host-ingested glucosinolates which are natural components of cruciferous vegetables to sulphoraphane, an organic small molecule with known anti-cancer activity.

    METHOD FOR ACCUMULATING PROTEIN IN PLANT CELLS
    5.
    发明申请
    METHOD FOR ACCUMULATING PROTEIN IN PLANT CELLS 有权
    用于在植物细胞中积累蛋白质的方法

    公开(公告)号:US20130347145A1

    公开(公告)日:2013-12-26

    申请号:US14003278

    申请日:2012-02-24

    IPC分类号: C12N9/24

    摘要: According to the present invention, a method for stably accumulating a target protein in plant cells or a plant body, and a transgenic plant in which protein has accumulated, are provided. The method of the present invention is a method for accumulating protein in plant cells, comprising accumulating a target protein or a protein deficient in an N-terminal region of the target protein in vacuoles of myrosin cells present in a multiple mutant, in which myrosin cells deficient in intravacuolar protein are also present in a plant body at locations other than around vascular bundles, by expressing a gene that encodes a target protein having an intracellular membrane system localization signal on the N-terminal and a vacuole localization signal on the C-terminal in the multiple mutant.

    摘要翻译: 根据本发明,提供了用于在植物细胞或植物体中稳定地积聚靶蛋白的方法和其中积累了蛋白质的转基因植物。 本发明的方法是在植物细胞中积聚蛋白质的方法,其特征在于:在存在于多突变体中的黑素瘤细胞的空泡中积聚靶蛋白的N末端区域的靶蛋白或缺失蛋白质的蛋白质, 通过在N末端表达编码具有细胞内膜系统定位信号的靶蛋白的基因和C末端的液泡定位信号,也存在于血管内蛋白质不足的植物体内, 在多重突变体中。

    Engineered Therapeutic Probiotic System and Method

    公开(公告)号:US20190209625A1

    公开(公告)日:2019-07-11

    申请号:US16240648

    申请日:2019-01-04

    摘要: The claimed invention provides therapeutic as well as protective measures against colorectal cancer by utilizing genetically modified gut bacteria (101) in conjunction with an optimized diet high in cruciferous vegetable intake. According to the claimed system and method, engineered gut bacteria maximize the therapeutic value of the cruciferous vegetable diet to eradicate, offset or prophylactically prevent the onset of colorectal cancer. In the claimed invention gut bacteria Escherichia coli bind specifically to the heparan sulphate proteoglycan on colorectal cancer cells to secrete the enzyme myrosinase to transform host-ingested glucosinolates which are natural components of cruciferous vegetables to sulphoraphane, an organic small molecule with known anti-cancer activity.

    TOPICAL COMPOSITION
    9.
    发明申请
    TOPICAL COMPOSITION 审中-公开
    主题成分

    公开(公告)号:US20170049676A1

    公开(公告)日:2017-02-23

    申请号:US15306891

    申请日:2015-04-21

    摘要: The inventors have observed that aqueous mustard seed extract appears to be cytotoxic to fibroblast cells. The cytotoxicity of the aqueous mustard seed extract appears to abate when the extract is heat treated at 120° C. for 15 minutes. The heat treated aqueous mustard seed extract when combined with exogenous myrosinase is not cytotoxic but can induce a modest increase in HO-1 content in cultured fibroblasts and thus would be expected to be useful in a topical composition for treating/preventing itchy skin, particularly the scalp. This invention thus relates to the provision of a topical composition for treating/preventing itchy skin, particularly the scalp.

    摘要翻译: 发明人已经观察到,芥子籽提取物似乎对成纤维细胞具有细胞毒性。 当提取物在120℃热处理15分钟时,芥子籽提取物的细胞毒性似乎降低了。 当与外源性黑芥子酶组合时,热处理的芥菜籽提取物不是细胞毒性的,但可以诱导培养的成纤维细胞中HO-1含量的适度增加,因此预期可用于治疗/预防瘙痒皮肤的局部组合物,特别是 头皮。 因此,本发明涉及提供用于治疗/预防瘙痒皮肤,特别是头皮的局部组合物。